Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing

Journal of Dermatological Science

Volumn 72, Issue 3, 2013, Pages 206-217

  Greaves, Nicholas S ^a   Ashcroft, Kevin J ^a   Baguneid, Mohamed ^a   Bayat, Ardeshir ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Acute wounds; Angiogenesis; Chronic wounds; Fibroplasia; Wound healing

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; CALPONIN; CHEMOKINE RECEPTOR CCR2; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; MATRIX PROTEIN; NEUTROPHIL COLLAGENASE; PLASMINOGEN ACTIVATOR INHIBITOR; PLATELET DERIVED GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; SOMATOMEDIN C; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UROKINASE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C;

ANGIOGENESIS; CELL FUNCTION; CELL INTERACTION; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; CHRONIC WOUND; ENDOTHELIUM CELL; ENZYME SYNTHESIS; FIBROBLAST; FIBROGENESIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; KERATINOCYTE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SCAR FORMATION; WOUND; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ACUTE WOUNDS; ANGIOGENESIS; CHRONIC WOUNDS; FIBROPLASIA; WOUND HEALING;

ANIMALS; CELL PROLIFERATION; FIBROBLASTS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RE-EPITHELIALIZATION; WOUND HEALING;

EID: 84887147557     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.07.008     Document Type: Review

References (172)

1. Kahn S.A., Beers R.J., Lentz C.W. Use of acellular dermal replacement in reconstruction of nonhealing lower extremity wounds. J Burn Care Res 2011, 32(1):124.
2. Eming S.A., Krieg T., Davidson J.M. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007, 127(3):514-525.
3. Singer A.J., Clark R. Cutaneous wound healing. N Engl J Med 1999, 341(10):738-746.
4. Gurtner G.C., Werner S., Barrandon Y., Longaker M.T. Wound repair and regeneration. Nature 2008, 453(7193):314-321.
5. Diegelmann R.F., Evans M.C. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004, 9(1):283-289.
6. Bayat A., McGrouther D., Ferguson M. Skin scarring. BMJ 2003, 326(7380):88-92.
7. Macri L., Clark R. Tissue engineering for cutaneous wounds: selecting the proper time and space for growth factors, cells and the extracellular matrix. Skin Pharmacol Physiol 2009, 22(2):83-93.
8. Bauer S.M., Bauer R.J., Velazquez O.C. Angiogenesis, vasculogenesis, and induction of healing in chronic wounds. Vasc Endovasc Surg 2005, 39(4):293-306.
9. Li J., Chen J., Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol 2007, 25(January-February (1)):9-18.
10. Telgenhoff D., Shroot B. Cellular senescence mechanisms in chronic wound healing. Cell Death Differ 2005, 12(7):695-698.
11. Clark R.A.F. Fibrin and wound healing. Ann N Y Acad Sci 2001, 936(1):355-367.
12. Welch M.P., Odland G.F., Clark R. Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol 1990, 110(1):133-145.
13. Clark R., Nielsen L.D., Welch M.P., McPherson J.M. Collagen matrices attenuate the collagen-synthetic response of cultured fibroblasts to TGF-beta. J Cell Sci 1995, 108(3):1251-1261.
14. Folkman J., D'Amore P.A. Blood vessel formation: what is its molecular basis?. Cell 1996, 87(7):1153.
15. Iruela-Arispe M., Dvorak H. Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemost 1997, 78(1):672.
16. Risau W. Mechanisms of angiogenesis. Nature 1997, 386(6626):671-674.
17. Pilcher B.K., Wang M., Qin X., Parks W.C., Senior R.M., Welgus H.G. Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity. Ann N Y Acad Sci 1999, 878(1):12-24.
18. Parks W.C. Matrix metalloproteinases in repair. Wound Repair Regen 1999, 7(6):423-432.
19. Opalenik S.R., Davidson J.M. Fibroblast differentiation of bone marrow-derived cells during wound repair. FASEB J 2005, 19(11):1561-1563.
20. Gray A.J., Bishop J.E., Reeves J.T., Laurent G.J. A alpha and B beta chains of fibrinogen stimulate proliferation of human fibroblasts. J Cell Sci 1993, 104(February (Pt 2)):409-413.
21. Xu J., Clark R.A. Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol 1996, 132(January (1/2)):239-249.
22. Greiling D., Clark R.A. Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci 1997, 110(April (Pt 7)):861-870.
23. Chrissouli S., Pratsinis H., Velissariou V., Anastasiou A., Kletsas D. Human amniotic fluid stimulates the proliferation of human fetal and adult skin fibroblasts: the roles of bFGF and PDGF and of the ERK and Akt signaling pathways. Wound Repair Regen 2010, 18(November-December (6)):643-654.
24. Giannouli C.C., Kletsas D. TGF-beta regulates differentially the proliferation of fetal and adult human skin fibroblasts via the activation of PKA and the autocrine action of FGF-2. Cell Signal 2006, 18(September (9)):1417-1429.
25. Hebda P.A., Klingbeil C.K., Abraham J.A., Fiddes J.C. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J Invest Dermatol 1990, 95(December (6)):626-631.
26. Akasaka Y., Ono I., Yamashita T., Jimbow K., Ishii T. Basic fibroblast growth factor promotes apoptosis and suppresses granulation tissue formation in acute incisional wounds. J Pathol 2004, 203(June (2)):710-720.
27. Ortega S., Ittmann M., Tsang S.H., Ehrlich M., Basilico C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci U S A 1998, 95(May (10)):5672-5677.
28. McGee G.S., Davidson J.M., Buckley A., Sommer A., Woodward S.C., Aquino A.M., et al. Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res 1988, 45(July (1)):145-153.
29. Garcia-de-Alba C., Becerril C., Ruiz V., Gonzalez Y., Reyes S., Garcia-Alvarez J., et al. Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing. Am J Respir Crit Care Med 2010, 182(November (9)):1144-1152.
30. Hartlapp I., Abe R., Saeed R.W., Peng T., Voelter W., Bucala R., et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 2001, 15(October (12)):2215-2224.
31. Abe R., Donnelly S.C., Peng T., Bucala R., Metz C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001, 166(June (12)):7556-7562.
32. Pilling D., Buckley C.D., Salmon M., Gomer R.H. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 2003, 171(November (10)):5537-5546.
33. Pilling D., Tucker N.M., Gomer R.H. Aggregated IgG inhibits the differentiation of human fibrocytes. J Leukoc Biol 2006, 79(June (6)):1242-1251.
34. Wang J.F., Jiao H., Stewart T.L., Shankowsky H.A., Scott P.G., Tredget E.E. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen 2007, 15(January-February (1)):113-121.
35. Ignotz R.A., Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986, 261(March (9)):4337-4345.
36. Oberringer M., Meins C., Bubel M., Pohlemann T. In vitro wounding: effects of hypoxia and transforming growth factor beta1 on proliferation, migration and myofibroblastic differentiation in an endothelial cell-fibroblast co-culture model. J Mol Histol 2008, 39(February (1)):37-47.
37. Koskela A., Engstrom K., Hakelius M., Nowinski D., Ivarsson M. Regulation of fibroblast gene expression by keratinocytes in organotypic skin culture provides possible mechanisms for the antifibrotic effect of reepithelialisation. Wound Repair Regen 2010, 18(September-October (5)):452-459.
38. Serini G., Bochaton-Piallat M.L., Ropraz P., Geinoz A., Borsi L., Zardi L., et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 1998, 142(August (3)):873-881.
39. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002, 3(May (5)):349-363.
40. Ehrlich H.P., Rajaratnam J.B. Cell locomotion forces versus cell contraction forces for collagen lattice contraction: an in vitro model of wound contraction. Tissue Cell 1990, 22(4):407-417.
41. Hinz B., Mastrangelo D., Iselin C.E., Chaponnier C., Gabbiani G. Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol 2001, 159(September (3)):1009-1020.
42. Monaco J.L., Lawrence W.T. Acute wound healing an overview. Clin Plast Surg 2003, 30(January (1)):1-12.
43. Hinz B., Celetta G., Tomasek J.J., Gabbiani G., Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 2001, 12(9):2730-2741.
44. 1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol 2003, 162(2):533-546.
45. Crider B.J., Risinger G.M., Haaksma C.J., Howard E.W., Tomasek J.J. Myocardin-related transcription factors A and B are key regulators of TGF-β1-induced fibroblast to myofibroblast differentiation. J Invest Dermatol 2011, 131(12):2378-2385.
46. Tomasek J.J., Haaksma C.J., Schwartz R.J., Howard E.W. Whole animal knockout of smooth muscle alpha-actin does not alter excisional wound healing or the fibroblast-to-myofibroblast transition. Wound Repair Regen 2013, 21(1):166-176.
47. Vaughan M.B., Howard E.W., Tomasek J.J. Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res 2000, 257(May (1)):180-189.
48. Goldberg M.T., Han Y.P., Yan C., Shaw M.C., Garner W.L. TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing. J Invest Dermatol 2007, 127(November (11)):2645-2655.
49. Singer I.I., Kawka D.W., Kazazis D.M., Clark R.A. In vivo co-distribution of fibronectin and actin fibers in granulation tissue: immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface. J Cell Biol 1984, 98(June (6)):2091-2106.
50. Burridge K., Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 1996, 12:463-518.
51. Varedi M., Tredget E.E., Ghahary A., Scott P.G. Stress-relaxation and contraction of a collagen matrix induces expression of TGF-beta and triggers apoptosis in dermal fibroblasts. Biochem Cell Biol 2000, 78(4):427-436.
52. Akasaka Y., Ono I., Tominaga A., Ishikawa Y., Ito K., Suzuki T., et al. Basic fibroblast growth factor in an artificial dermis promotes apoptosis and inhibits expression of alpha-smooth muscle actin, leading to reduction of wound contraction. Wound Repair Regen 2007, 15(May-June (3)):378-389.
53. Ishiguro S., Akasaka Y., Kiguchi H., Suzuki T., Imaizumi R., Ishikawa Y., et al. Basic fibroblast growth factor induces down-regulation of alpha-smooth muscle actin and reduction of myofibroblast areas in open skin wounds. Wound Repair Regen 2009, 17(July-August (4)):617-625.
54. Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim Biophys Acta 2004, 1654(1):13-22.
55. Wijelath E.S., Murray J., Rahman S., Patel Y., Ishida A., Strand K., et al. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res 2002, 91(1):25-31.
56. Hangai M., Kitaya N., Xu J., Chan C.K., Kim J.J., Werb Z., et al. Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis. Am J Pathol 2002, 161(4):1429-1437.
57. Pepper M.S. Extracellular proteolysis and angiogenesis. Thromb Haemost 2001, 86(1):346-355.
58. Xu J., Rodriguez D., Petitclerc E., Kim J.J., Hangai M., Yuen S.M., et al. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 2001, 154(5):1069-1080.
59. Saksela O., Rifkin D.B. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol 1990, 110(3):767-775.
60. Petitclerc E., Boutaud A., Prestayko A., Xu J., Sado Y., Ninomiya Y., et al. New functions for non-collagenous domains of human collagen type IV novel integrin ligands inhibiting angiogenesis and tumor growthin vivo. J Biol Chem 2000, 275(11):8051-8061.
61. Armstrong L.C., Björkblom B., Hankenson K.D., Siadak A.W., Stiles C.E., Bornstein P. Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism. Mol Biol Cell 2002, 13(6):1893-1905.
62. Davies C.d.L., Melder R.J., Munn L.L., Mouta-Carreira C., Jain R.K., Boucher Y. Decorin inhibits endothelial migration and tube-like structure formation: role of thrombospondin-1. Microvasc Res 2001, 62(1):26-42.
63. Tolsma S.S., Volpert O.V., Good D.J., Frazier W.A., Polverini P.J., Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 1993, 122(2):497-511.
64. Guo N.-h., Krutzsch H.C., Inman J.K., Roberts D.D. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res 1997, 57(9):1735-1742.
65. Folkman J. Angiogenesis: initiation and control. Ann N Y Acad Sci 1982, 401:212-227.
66. Kalebic T., Garbisa S., Glaser B., Liotta L.A. Basement membrane collagen: degradation by migrating endothelial cells. Science 1983, 221(July (4607)):281-283.
67. Sahni A., Sporn L.A., Francis C.W. Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2. J Biol Chem 1999, 274(May (21)):14936-14941.
68. Sahni A., Francis C.W. Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires alphavbeta3. Blood 2004, 104(December (12)):3635-3641.
69. Brooks P.C., Clark R.A., Cheresh D.A. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994, 264(April (5158)):569-571.
70. Brooks P.C., Stromblad S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G., et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996, 85(May (5)):683-693.
71. Pellegrini L. Role of heparan sulfate in fibroblast growth factor signalling: a structural view. Curr Opin Struct Biol 2001, 11(October (5)):629-634.
72. Koolwijk P., van Erck M.G., de Vree W.J., Vermeer M.A., Weich H.A., Hanemaaijer R., et al. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol 1996, 132(March (6)):1177-1188.
73. Kroon M.E., Koolwijk P., van der Vecht B., van Hinsbergh V.W. Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix. Blood 2000, 96(October (8)):2775-2783.
74. Banks R.E., Forbes M.A., Kinsey S.E., Stanley A., Ingham E., Walters C., et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998, 77(March (6)):956-964.
75. Gaudry M., Bregerie O., Andrieu V., El Benna J., Pocidalo M.A., Hakim J. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 1997, 90(November (10)):4153-4161.
76. Ohtani T., Mizuashi M., Ito Y., Aiba S. Cadexomer as well as cadexomer iodine induces the production of proinflammatory cytokines and vascular endothelial growth factor by human macrophages. Exp Dermatol 2007, 16(April (4)):318-323.
77. Namiki A., Brogi E., Kearney M., Kim E.A., Wu T., Couffinhal T., et al. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 1995, 270(December (52)):31189-31195.
78. Stavri G.T., Zachary I.C., Baskerville P.A., Martin J.F., Erusalimsky J.D. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 1995, 92(July (1)):11-14.
79. Detmar M., Brown L.F., Berse B., Jackman R.W., Elicker B.M., Dvorak H.F., et al. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol 1997, 108(March (3)):263-268.
80. Nissen N.N., Polverini P.J., Koch A.E., Volin M.V., Gamelli R.L., DiPietro L.A. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998, 152(June (6)):1445-1452.
81. Sahni A., Francis C.W. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000, 96(December (12)):3772-3778.
82. Koolwijk P., Peters E., van der Vecht B., Hornig C., Weich H.A., Alitalo K., et al. Involvement of VEGFR-2 (kdr/flk-1) but not VEGFR-1 (flt-1) in VEGF-A and VEGF-C-induced tube formation by human microvascular endothelial cells in fibrin matrices in vitro. Angiogenesis 2001, 4(1):53-60.
83. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., Heldin C.H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994, 269(October (43)):26988-26995.
84. Senger D.R., Ledbetter S.R., Claffey K.P., Papadopoulos-Sergiou A., Peruzzi C.A., Detmar M. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol 1996, 149(July (1)):293-305.
85. Senger D.R., Claffey K.P., Benes J.E., Perruzzi C.A., Sergiou A.P., Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci U S A 1997, 94(December (25)):13612-13617.
86. Mace K.A., Yu D.H., Paydar K.Z., Boudreau N., Young D.M. Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair. Wound Repair Regen 2007, 15(September-October (5)):636-645.
87. Kimura H., Esumi H. Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim Pol 2003, 50(1):49-59.
88. Knighton D.R., Silver I.A., Hunt T.K. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 1981, 90(August (2)):262-270.
89. Stockmann C., Kirmse S., Helfrich I., Weidemann A., Takeda N., Doedens A., et al. A wound size-dependent effect of myeloid cell-derived vascular endothelial growth factor on wound healing. J Invest Dermatol 2010, 131(3):797-801.
90. Pollard J.W. Trophic macrophages in development and disease. Nat Rev Immunol 2009, 9(4):259-270.
91. Willenborg S., Lucas T., van Loo G., Knipper J.A., Krieg T., Haase I., et al. CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair. Blood 2012, 120(3):613-625.
92. Lucas T., Waisman A., Ranjan R., Roes J., Krieg T., Müller W., et al. Differential roles of macrophages in diverse phases of skin repair. J Immunol 2010, 184(7):3964-3977.
93. Rossiter H., Barresi C., Pammer J., Rendl M., Haigh J., Wagner E.F., et al. Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation. Cancer Res 2004, 64(10):3508-3516.
94. Partanen J., Armstrong E., Makela T.P., Korhonen J., Sandberg M., Renkonen R., et al. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 1992, 12(April (4)):1698-1707.
95. Staton C.A., Valluru M., Hoh L., Reed M.W., Brown N.J. Angiopoietin-1, angiopoietin-2 and Tie-2 receptor expression in human dermal wound repair and scarring. Br J Dermatol 2010, 163(November (5)):920-927.
96. Papapetropoulos A., Fulton D., Mahboubi K., Kalb R.G., O'Connor D.S., Li F., et al. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 2000, 275(March (13)):9102-9105.
97. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Oldmixon E.H., et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998, 282(October (5388)):468-471.
98. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286(December (5449)):2511-2514.
99. Kumar I., Staton C.A., Cross S.S., Reed M.W., Brown N.J. Angiogenesis, vascular endothelial growth factor and its receptors in human surgical wounds. Br J Surg 2009, 96(December (12)):1484-1491.
100. Romano Di Peppe S., Mangoni A., Zambruno G., Spinetti G., Melillo G., Napolitano M., et al. Adenovirus-mediated VEGF (165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice. Gene Ther 2002, 9(19):1271.
101. Galiano R.D., Tepper O.M., Pelo C.R., Bhatt K.A., Callaghan M., Bastidas N., et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004, 164(6):1935-1947.
102. Vranckx J.J., Yao F., Petrie N., Augustinova H., Hoeller D., Visovatti S., et al. In vivo gene delivery of Ad-VEGF121 to full-thickness wounds in aged pigs results in high levels of VEGF expression but not in accelerated healing. Wound Repair Regen 2005, 13(1):51-60.
103. Roman C.D., Choy H., Nanney L., Riordan C., Parman K., Johnson D., et al. Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats. J Surg Res 2002, 105(1):43-47.
104. Wilgus T.A., Ferreira A.M., Oberyszyn T.M., Bergdall V.K., DiPietro L.A. Regulation of scar formation by vascular endothelial growth factor. Lab Invest 2008, 88(6):579-590.
105. Wu W.-S., Wang F.-S., Yang K.D., Huang C.-C., Kuo Y.-R. Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation. J Invest Dermatol 2006, 126(6):1264-1271.
106. Zhang N., Fang Z., Contag P.R., Purchio A.F., West D.B. Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse. Blood 2004, 103(2):617-626.
107. Bloch W., Huggel K., Sasaki T., Grose R., Bugnon P., Addicks K., et al. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing. FASEB J 2000, 14(15):2373-2376.
108. DeVore R.F., Hellerqvist C.G., Wakefield G.B., Wamil B.D., Thurman G.B., Minton P.A., et al. Phase I study of the antineovascularization drug CM101. Clin Cancer Res 1997, 3(3):365-372.
109. Ko J., Ross J., Awad H., Hurwitz H., Klitzman B. The effects of ZD6474, an inhibitor of VEGF signaling, on cutaneous wound healing in mice. J Surg Res 2005, 129(2):251-259.
110. Haynes J.H., Johnson D.E., Mast B.A., Diegelmann R.F., Salzberg D.A., Cohen I.K., et al. Platelet-derived growth factor induces fetal wound fibrosis. J Pediatr Surg 1994, 29(11):1405-1408.
111. Liu W., Wang D., Cao Y. TGF-beta: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy. Curr Gene Ther 2004, 4(1):123-136.
112. Liechty K.W., Crombleholme T.M., Cass D.L., Martin B., Adzick N.S. Diminished interleukin-8 (IL-8) production in the fetal wound healing response. J Surg Res 1998, 77(1):80-84.
113. Loots M.A.M., Lamme E.N., Zeegelaar J., Mekkes J.R., Bos J.D., Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998, 111(5):850-857.
114. Fonder M.A., Lazarus G.S., Cowan D.A., Aronson-Cook B., Kohli A.R., Mamelak A.J. Treating the chronic wound: a practical approach to the care of nonhealing wounds and wound care dressings. J Am Acad Dermatol 2008, 58(2):185-206.
115. Singh A., Halder S., Chumber S., Misra M.C., Sharma L.K., Srivastava A., et al. Meta-analysis of randomized controlled trials on hydrocolloid occlusive dressing versus conventional gauze dressing in the healing of chronic wounds. Asian J Surg 2004, 27(4):326-332.
116. Cornwall J.V., Doré C.J., Lewis J. Leg ulcers: epidemiology and aetiology. Br J Surg 1986, 73(9):693-696.
117. Abbade L.P.F., Lastória S. Venous ulcer: epidemiology, physiopathology, diagnosis and treatment. Int J Dermatol 2005, 44(6):449-456.
118. Greaves N.S., Iqbal S.A., Baguneid M., Bayat A. The role of skin substitutes in the management of chronic cutaneous wounds. Wound Repair Regen 2013, 21:194210.
119. Palolahti M., Lauharanta J., Stephens R.W., Kuusela P., Vaheri A. Proteolytic activity in leg ulcer exudate. Exp Dermatol 1993, 2(1):29-37.
120. Harris I., Yee K., Walters C., Cunliffe W.J., Kearney J., Wood E., et al. Cytokine and protease levels in healing and non-healing chronic venous leg ulcers. Exp Dermatol 1995, 4(6):342-349.
121. Saarialho-Kere U. Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res 1998, 290(14):47-54.
122. Barrick B., Campbell E.J., Owen C.A. Leukocyte proteinases in wound healing: roles in physiologic and pathologic processes. Wound Repair Regen 1999, 7(6):410-422.
123. Grinnell F., Ho C.H., Wysocki A. Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol 1992, 98(4):410-416.
124. Grinnell F., Zhu M. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, α1-proteinase inhibitor, and α2-macroglobulin. J Invest Dermatol 1996, 106(2):335-341.
125. Wenk J., Foitzik A., Achterberg V., Sabiwalsky A., Dissemond J., Meewes C., et al. Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. J Invest Dermatol 2001, 116(6):833-839.
126. Norgauer J., Hildenbrand T., Idzko M., Panther E., Bandemir E., Hartmann M., et al. Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane-type matrix metalloproteinases in venous leg ulcers. Br J Dermatol 2002, 147(6):1180-1186.
127. Mustoe T.A., O'Shaughnessy K., Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg 2006, 117(7S):35S.
128. Stanley A., Osler T. Senescence and the healing rates of venous ulcers. J Vasc Surg 2001, 33(6):1206-1211.
129. Cook H., Stephens P., Davies K.J., Harding K.G., Thomas D.W. Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J Invest Dermatol 2000, 115(2):225-233.
130. Brem H., Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007, 117(5):1219.
131. Harding K., Morris H., Patel G. Healing chronic wounds. BMJ 2002, 324(7330):160-163.
132. Higley H., Ksander G., Gerhardt C., Falanga V. Extravasation of macromolecules and possible trapping of transforming growth factor-β in venous ulceration. Br J Dermatol 1995, 132(1):79-85.
133. Wlaschek M., Peus D., Achterberg V., Meyer-Ingold W., Scharffetter-Kochanek K. Protease inhibitors protect growth factor activity in chronic wounds. Br J Dermatol 1997, 137(4):646-663.
134. Lauer G., Sollberg S., Cole M., Flamme I., Stürzebecher J., Mann K., et al. Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol 2000, 115(1):12-18.
135. Bucalo B., Eaglstein W.H., Falanga V. Inhibition of cell proliferation by chronic wound fluid. Wound Repair Regen 1993, 1(3):181-186.
136. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83(3):835-870.
137. Delavary B.M., van der Veer W.M., van Egmond M., Niessen F.B., Beelen R.H. Macrophages in skin injury and repair. Immunobiology 2011, 216(7):753-762.
138. Hu Y., Liang D., Li X., Liu H.-H., Zhang X., Zheng M., et al. The role of interleukin-1 in wound biology. Part II: in vivo and human translational studies. Anesth Analg 2010, 111(6):1534-1542.
139. Strid J., Hourihane J., Kimber I., Callard R., Strobel S. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol 2004, 34(August (8)):2100-2109.
140. Nickoloff B.J., Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 1994, 30(April (4)):535-546.
141. Strid J., Tigelaar R.E., Hayday A.C. Skin immune surveillance by T cells-a new order?. Semin Immunol 2009, 21(June (3)):110-120.
142. Artuc M., Hermes B., Steckelings U.M., Grutzkau A., Henz B.M. Mast cells and their mediators in cutaneous wound healing--active participants or innocent bystanders?. Exp Dermatol 1999, 8(February (1)):1-16.
143. Egozi E.I., Ferreira A.M., Burns A.L., Gamelli R.L., Dipietro L.A. Mast cells modulate the inflammatory but not the proliferative response in healing wounds. Wound Repair Regen 2003, 11(January-February (1)):46-54.
144. Edwards M., Jones D. Programmed cell death in human acute cutaneous wounds. J Cutan Pathol 2001, 28(March (3)):151-155.
145. Johnston A., Gudjonsson J.E., Aphale A., Guzman A.M., Stoll S.W., Elder J.T. EGFR and IL-1 signaling synergistically promote keratinocyte antimicrobial defenses in a differentiation-dependent manner. J Invest Dermatol 2010, 131(2):329-337.
146. Wenczak B.A., Lynch J.B., Nanney L.B. Epidermal growth factor receptor distribution in burn wounds. Implications for growth factor-mediated repair. J Clin Invest 1992, 90(December (6)):2392-2401.
147. Schultz G., Rotatori D.S., Clark W.E.G.F. TGF-alpha in wound healing and repair. J Cell Biochem 1991, 45(April (4)):346-352.
148. Yang L., Scott P.G., Dodd C., Medina A., Jiao H., Shankowsky H.A., et al. Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 2005, 13(July-August (4)):398-404.
149. Workalemahu G., Foerster M., Kroegel C., Braun R.K. Human gamma delta-T lymphocytes express and synthesize connective tissue growth factor: effect of IL-15 and TGF-beta 1 and comparison with alpha beta-T lymphocytes. J Immunol 2003, 170(January (1)):153-157.
150. V mice. Int Arch Allergy Immunol 2010, 151(1):80-88.
151. Sun T., Adra S., Smallwood R., Holcombe M., MacNeil S. Exploring hypotheses of the actions of TGF-beta1 in epidermal wound healing using a 3D computational multiscale model of the human epidermis. PLoS ONE 2009, 4(12):e8515.
152. Kankuri E., Cholujova D., Comajova M., Vaheri A., Bizik J. Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res 2005, 65(November (21)):9914-9922.
153. Conway K., Price P., Harding K.G., Jiang W.G. The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing. Wound Repair Regen 2006, 14(January-February (1)):2-10.
154. Anitua E., Andia I., Ardanza B., Nurden P., Nurden A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004, 91(January (1)):4-15.
155. Xie J., Bian H., Qi S., Xu Y., Tang J., Li T., et al. Effects of basic fibroblast growth factor on the expression of extracellular matrix and matrix metalloproteinase-1 in wound healing. Clin Exp Dermatol 2008, 33(March (2)):176-182.
156. Chrissouli S., Pratsinis H., Velissariou V., Anastasiou A., Kletsas D. Human amniotic fluid stimulates the proliferation of human fetal and adult skin fibroblasts: the roles of bFGF and PDGF and of the ERK and Akt signaling pathways. Wound Repair Regen 2010, 18(6):643-654.
157. Varcoe R.L., Mikhail M., Guiffre A.K., Pennings G., Vicaretti M., Hawthorne W.J., et al. The role of the fibrocyte in intimal hyperplasia. J Thromb Haemost 2006, 4(May (5)):1125-1133.
158. Gillitzer R., Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 2001, 69(April (4)):513-521.
159. Frazier K., Williams S., Kothapalli D., Klapper H., Grotendorst G.R. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996, 107(September (3)):404-411.
160. Koskela A., Engström K., Hakelius M., Nowinski D., Ivarsson M. Regulation of fibroblast gene expression by keratinocytes in organotypic skin culture provides possible mechanisms for the antifibrotic effect of reepithelialization. Wound Repair Regen 2010, 18(5):452-459.
161. Chen L., Tredget E.E., Wu P.Y.G., Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE 2008, 3(4):e1886.
162. Sharp L.L., Jameson J.M., Cauvi G., Havran W.L. Dendritic epidermal T cells regulate skin homeostasis through local production of insulin-like growth factor 1. Nat Immunol 2005, 6(January (1)):73-79.
163. Staton C., Valluru M., Hoh L., Reed M., Brown N. Angiopoietin-1 angiopoietin-2 and Tie-2 receptor expression in human dermal wound repair and scarring. Br J Dermatol 2010, 163(5):920-927.
164. Toriseva M., Kahari V.M. Proteinases in cutaneous wound healing. Cell Mol Life Sci 2009, 66(January (2)):203-224.
165. Schaller J., Gerber S.S. The plasmin-antiplasmin system: structural and functional aspects. Cell Mol Life Sci 2011, 68(5):785-801.
166. Schafer B.M., Maier K., Eickhoff U., Todd R.F., Kramer M.D. Plasminogen activation in healing human wounds. Am J Pathol 1994, 144(June (6)):1269-1280.
167. Vaalamo M., Weckroth M., Puolakkainen P., Kere J., Saarinen P., Lauharanta J., et al. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol 1996, 135(July (1)):52-59.
168. Ando Y., Jensen P.J. Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro. J Cell Physiol 1996, 167(June (3)):500-511.
169. Lian X., Yang L., Gao Q., Yang T. IL-1alpha is a potent stimulator of keratinocyte tissue plasminogen activator expression and regulated by TGF-beta1. Arch Dermatol Res 2008, 300(April (4)):185-193.
170. Ghosh A.K., Vaughan D.E. PAI-1 in tissue fibrosis. J Cell Physiol 2012, 227(2):493-507.
171. Wu Y., Zhang Q., Ann D.K., Akhondzadeh A., Duong H.S., Messadi D.V., et al. Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. Am J Physiol Cell Physiol 2004, 286(April (4)):C905-C912.
172. Providence K.M., Higgins P.J. PAI-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair. J Cell Physiol 2004, 200(August (2)):297-308.